Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Epigenetic Biomarkers Predict CVD Risk
Disease Discoveries

Epigenetic Biomarkers Predict CVD Risk

By Will DossJun 28, 2022
Share
Facebook Twitter Email
Yinan Zheng, ’17 PhD, assistant professor of Preventive Medicine in the Division of Cancer Epidemiology and Prevention, was lead author of the study published in the journal Circulation.
Yinan Zheng, ’17 PhD, assistant professor of Preventive Medicine in the Division of Cancer Epidemiology and Prevention, was lead author of the study published in the journal Circulation.

Epigenetic biomarkers may reflect past cardiovascular health exposures and predict cardiovascular disease in the future, according to a Northwestern Medicine study published in the journal Circulation.

These biomarkers measured around midlife reveal valuable health information from a patient’s past, according to Yinan Zheng, ’17 PhD, assistant professor of Preventive Medicine in the Division of Cancer Epidemiology and Prevention and lead author of the study.

“Our past exposures to obesity, elevated blood pressure, blood sugar and cholesterol leave ‘epigenetic footprints’ for us to better inform the development of cardiovascular diseases,” Zheng said.

Cardiovascular health from young adulthood is strongly associated with future risk of cardiovascular disease (CVD) and total mortality. In the current study, investigators defined a cumulative cardiovascular health score including body mass index, blood pressure, cholesterol and fasting glucose. They applied this score to more than 1,000 patients in the Coronary Artery Risk Development in Young Adults (CARDIA) study, a long-term study of cardiovascular risk factors which began in 1983.

Lifang Hou, MD, PhD, chief of Cancer Epidemiology and Prevention in the Department of Preventive Medicine and co-senior author of the study.
Lifang Hou, MD, PhD, chief of Cancer Epidemiology and Prevention in the Department of Preventive Medicine, was co-senior author of the study.

In addition, the scientists measured DNA methylation —epigenetic changes that regulate gene expression — in patient blood samples at two different time points collected around 40 years of age. DNA methylation can be modified gradually through long-term exposures to cardiovascular risk factors and the investigators hypothesized that it might better capture risk of CVD in conjunction with conventional CVD risk factors.

“These epigenetic markers integrate our exposures over decades to environmental factors like air pollution and to behavioral factors like our diet and physical activity,” said Donald Lloyd-Jones, MD, ScM, chair and the Eileen M. Foell Professor of Preventive Medicine and co-senior author of the study. “In some ways, your epigenome is even more important than your inherited DNA code in determining your health.”

The scientists found changes in 45 DNA methylation markers that were prospectively associated with 15 to 20 years of cardiovascular health prior to the measurement of the markers. For example, poorer cardiovascular health was associated with less methylation in the gene CPT1A, “switching on” expression of the gene.

The gene CPT1A codes for a lipid metabolism protein that’s important for burning fat, but a long-term poor diet can “exhaust” those proteins and contribute to fat buildup and eventual CVD, Zheng said.

Donald Lloyd-Jones, MD, ScM, chair and the Eileen M. Foell Professor of Preventive Medicine and co-senior author of the study.
Donald Lloyd-Jones, MD, ScM, chair and the Eileen M. Foell Professor of Preventive Medicine, was co-senior author of the study.

Investigators also created a methylation risk score and used it to predict risk of coronary artery calcification (CAC), a condition that often presages later CVD. This methylation score was able to predict future clinical CVD events in the Framingham Heart Study, another large longitudinal cohort.

“Clinicians can use the score just like the CVH metrics by applying thresholds to determine the CVD risk level, such as low, moderate or high,” said Lifang Hou, MD, PhD, chief of Cancer Epidemiology and Prevention in the Department of Preventive Medicine and co-senior author of the study. “However, future larger population studies are needed to determine such a threshold.”

Hou is also director of the Center for Global Oncology, part of the Robert J. Havey, MD Institute for Global Health and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Lloyd-Jones is also principal investigator of the CARDIA study Chicago site.

This study was supported by American Heart Association grants 17SFRN33700278 and 14SFRN20790000, and National Institute on Aging grant R21AG068955.

Cancer Cardiology Preventive Medicine Research
Share. Facebook Twitter Email

Related Posts

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

Comments are closed.

Latest News

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023

Humans are Not Just Big Mice: Identifying Science’s Muscle-Scaling Problem

Mar 20, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230315_NM036
20230315_NM046
20230315_NM134
20230315_NM205
20230315_NM206
20230315_NM132
20230315_NM130
20230315_NM082
20230315_NM063
20230315_NM058
20230315_NM030
20230315_NM038

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.